Fish oil for induction of remission in ulcerative colitis (Q24243295)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Fish oil for induction of remission in ulcerative colitis (English)

0 references

1 reference

0 references

1 reference

Maartje De Ley

1

0 references

Rien de Vos

series ordinal

2

0 references

Daniel W Hommes

series ordinal

3

0 references

Pieter C Stokkers

series ordinal

4

0 references

publication date

17 October 2007

0 references

published in

0 references

cites work

Dietary Supplementation with Fish Oil in Ulcerative Colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Distal proctocolitis and n-3 polyunsaturated fatty acids (n-3 PUFAs): the mucosal effect in situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Distal procto-colitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Decreased oxidative stress in patients with ulcerative colitis supplemented with fish oil ω-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Short chain fatty acid rectal irrigation for left-sided ulcerative colitis: a randomised, placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

A double-blind, randomized, placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Assessing the quality of randomized trials: reliability of the Jadad scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

A critical review of epidemiological studies in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Toward using confidence intervals to compare correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

Treatment of diversion colitis by short-chain fatty acids. Prospective and double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Treatment of distal ulcerative colitis with short-chain fatty acid enemas. A placebo-controlled trial. German-Austrian SCFA Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

n-3 fatty acids only delay early relapse of ulcerative colitis in remission

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Comparison of omega-3 fatty acids and sulfasalazine in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Safety considerations of polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Treatment of ulcerative colitis with fish oil n--3-omega-fatty acid: an open trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Therapeutic potential of fish oil in the treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Short-chain fatty acid topical treatment in distal ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease--a randomized, placebo-controlled, double-blind cross-over trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

Distal procto-colitis, natural cytotoxicity, and essential fatty acids

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD005986.PUB2

7 January 2021

10.1002/14651858.CD005986.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

4711706

4711706

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference